Withings Body Scan 2
The World’s First Science-Backed Longevity Station
CES 2026 Innovation Award Honoree
Redefining Preventive Health at Home
Unveiled at CES 2026, Body Scan 2 transforms your daily weigh-in into a powerful 90-second health assessment — tracking over 60 biomarkers for early detection of imbalances years before symptoms appear.
Hypertension Risk Notification
First-ever on a home scale — cuff-free AI-powered risk alerts for arterial hypertension, a leading stroke risk factor often underdiagnosed.
Impedance Cardiography (ICG)
Full assessment of cardiac pumping efficiency, heart age, reactivity, and performance — combined with 6-lead ECG for rhythm and Atrial Fibrillation detection.
Ultra-High-Frequency Bioimpedance Spectroscopy (BIS)
In-depth cellular health, active cell mass, metabolic efficiency, and early glycemic dysregulation insights — previously exclusive to clinical settings.
Arterial Elasticity & Vascular Age
Pulse Wave Velocity (PWV) measures stiffness across arms and legs — mapping vascular aging and future cardiovascular risk.
Health Trajectory Score
AI-driven personalized baselines, deviation detection, and recommendations to extend your healthspan — powered by billions of Withings measurements.
Premium Everyday Design
Tempered glass platform, retractable handle with high-res color LCD, 15-month rechargeable battery, Wi-Fi/Bluetooth sync, GDPR/HIPAA compliant.
Key Breakthrough Technologies
- First on a home scale: Hypertension risk via exclusive AI model
- First on a home scale: Impedance Cardiography (ICG) for heart pumping efficiency
- First on a home scale: Ultra-high-frequency BIS for cellular & glycemic insights
- 6-lead ECG + Pulse Wave Velocity + full-body electrode array (8 on platform + 4 in handle)
- 90-second multimodal scan covering cardiovascular, metabolic, and cellular systems
Share:
Why BodyScan Is a Game-Changer for Your Health.
Withings × Abbott | Cooperation at CES 2026